PolyArginine Treated vEiN grafTs (PATENT)

NCT00264706 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

25

Enrollment

INDUSTRY

Sponsor class

Stopped Reformulation of test compound

Conditions

Saphenous Vein Graft Disease

Interventions

DRUG: Nona-L-arginine

Sponsor

Lumen Therapeutics